US FDA conclude Lupin’s Nagpur Unit-1 facility inspection with zero observation
Lupin announced that the United States Food and Drug Administration (US FDA) has completed a product specific Pre-Approval…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
AI in pharma: Disruption, displacement, and a new digital dawn
Dr Rajendra Pratap Gupta, Chairman of the Academy of Digital Health Sciences and Former Advisor to the Health Minister of India,…
Kyasanur Forest Disease – How far is a regulatory approved vaccine?
Dr Priyabrata Pattnaik, Former Deputy MD, Indian Immunologicals, informs about the Kyasanur Forest Disease (KFD), a zoonotic viral…
India to host CPHI & PMEC India 2025 from 25–27 November at India Expo Mart, Greater Noida
Event organised by Informa Markets in India to bring over 2,000 exhibitors and 50,000 industry participants from more than 120…
ENTOD Pharmaceuticals supports National Myopia Week 2025 with nationwide awareness campaign
The initiative aims to expand preventive education, screenings, and community engagement across 450 districts in India
Pfizer completes acquisition of Metsera for USD 7 billion to expand obesity and cardiometabolic…
The deal adds multiple clinical-stage candidates, including GLP-1 and amylin assets, as Metsera becomes a wholly owned Pfizer…
Bry-Air launches P80x dehumidifier using MOF technology for the pharma industry
The P80x features MOF-based MIRACLE Next-Gen Rotor and heat pump compatibility for reduced energy use and lower regeneration…
Lupin launches Risperidone extended-release injectable suspension in the U.S. with 180-day CGT…
The launch marks Lupin’s first product using PrecisionSphereTM, the long-acting injectable platform developed by Nanomi B.V.
Zydus Lifesciences receives USFDA approval for Diroximel Fumarate delayed-release capsules
The approval covers the treatment of relapsing forms of multiple sclerosis in adults, with production to take place at Zydus…
Alembic receives USFDA approval for Dexlansoprazole delayed-release capsules
Alembic Pharmaceuticals secures final USFDA approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg,…